Testing effectiveness (Phase 2)Study completedNCT01148797
What this trial is testing
Evaluate the Safety and Efficacy of Canakinumab in Pediatric Patients With Colchicine Intolerant or Colchicine Resistant Familial Mediterranean Fever (FMF)
Who this might be right for
Colchicine Resistant/Intolerant Familial Mediterranean Fever
Novartis Pharmaceuticals 15